Targeted therapy using nanotechnology: focus on cancer.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery Systems

Background:

• Nanomaterials offer unique properties like large surface area and long circulation for advanced biomedical applications.
• Engineered nanoparticles hold potential to revolutionize disease diagnosis and treatment, particularly in oncology.
• Challenges remain in optimizing nanomaterial properties for effective tumor targeting and controlled drug release.

Purpose of the Study:

• To review the development and application of engineered nanoscale materials in biomedical fields.
• To highlight the potential of nanomedicines in improving cancer diagnosis and therapy.
• To discuss obstacles in nanomedicine translation and recent advancements in targeted nanoparticle development.

Main Methods:

• Exploration of nanotechnology and biotechnology advancements in creating nanoscale materials.
• Focus on the design of nanoprototypes for cancer diagnosis and treatment.
• Investigation of functionalized nanoparticles for targeted drug delivery.

Main Results:

• Nanomaterials demonstrate potential for enhanced imaging contrast agents and targeted delivery of bioactive agents.
• Development of programmable nanotherapeutic formulations, such as BIND-014, combining targeted and controlled-release polymer technologies.
• BIND-014 has entered Phase II clinical trials for solid tumors, showcasing successful tumor targeting and eradication potential.

Conclusions:

• Engineered nanomaterials offer significant promise for revolutionizing medical diagnostics and therapeutics.
• Targeted and controlled-release nanotechnologies are crucial for overcoming limitations in nanomedicine delivery.
• BIND-014 exemplifies a validated targeted nanosystem with optimal properties for effective tumor eradication.